beta - fireinvestment.io logo beta - fireinvestment.io logo Home Markets News Resources Burn it

Burn it

Login Register

eLife 2023-03-07 20:13:37

Scientists discover new lead in hunt for myeloma drug

Newswise — A molecule involved in fat transport and metabolism is key to the progression of the malignant blood cancer multiple myeloma, researchers report today in  . The molecule – called fatty acid binding protein 5 (FABP5) – could be used as a marker to help doctors identify people with more aggressive forms of myeloma and may represent a new target for multiple myeloma treatment, which is urgently needed. Multiple myeloma accounts for roughly 10% of blood cancers and only around half of people who develop the disease will live beyond five years.

Read the Disclaimer : All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer.